Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167956 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Domenico Rocco und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Salerno, Italy. Hauptthemen laut MEDLINE: Cell Movement, Thyroid Cancer, Papillary, Matrix Metalloproteinase 2, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Papillary thyroid carcinoma (PTC), while often having a favorable prognosis, can progress to aggressive forms. Matrix metalloproteinases (MMPs) are crucial in extracellular matrix remodeling and are implicated in tumor invasion and metastasis. This study investigated MMP expression and activity in PTC and the efficacy of two selective MMP inhibitors in suppressing PTC cell migration and invasion. The analysis of RNA-seq data from the TCGA-THCA dataset highlighted the overexpression of MMP-14 in PTC, a key upstream activator of several MMPs, including MMP-2 and, indirectly, MMP-9. This elevation correlated with disease status and recurrence risk. Validation in a cell model, using PTC lines (K1 and BCPAP) and non-tumoral thyroid cells (Nthy-ori 3-1), showed markedly increased MMP-14 activity in PTC lines (6-fold in K1; 11-fold in BCPAP). MMP-9 activity was also substantially elevated (386-fold in K1; 131-fold in BCPAP), along with increased MMP-2 activity. We then tested selective inhibitors. NSC405020, an MMP-14 inhibitor, reduced K1 cell migration by 56.52% and invasion by 67.3%. Gallic acid, an MMP-2 and MMP-9 inhibitor, reduced K1 cell migration to 60.3% and invasion to 33.3% relative to the controls. These findings suggest that elevated MMP activity is a hallmark of aggressive PTC, underscoring MMPs’ role in cancer progression. Targeting MMPs, particularly with agents like NSC405020 and gallic acid, presents a promising therapeutic strategy to disrupt PTC tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Salerno, Italy.
ORCID-Profile: Domenico Rocco, Vincenzo Marotta, Domenico Palumbo
Zitieren
APA
Rocco, D., Marotta, V., Palumbo, D., & Vitale, M. (2025). Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167956
Vancouver
Rocco D, Marotta V, Palumbo D, Vitale M. Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167956
BibTeX
@article{Rocco2025,
author = {Rocco, Domenico and Marotta, Vincenzo and Palumbo, Domenico and Vitale, Mario},
title = {Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167956}
}
EUVIMED